Is Broadcom Stock a Millionaire Maker?
Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…
Buy
62
NNGRY Quote, Financials, Valuation and Earnings
Last price:
$31.14
Seasonality move
:
1.76%
Day range:
$30.86 - $30.96
52-week range:
$20.97 - $31.24
Dividend yield:
5.9%
P/E ratio:
10.38x
P/S ratio:
1.41x
P/B ratio:
0.74x
Volume:
15.7K
Avg. volume:
34.9K
1-year change:
33.09%
Market cap:
$16.5B
Revenue:
$12.1B
EPS (TTM):
$2.98
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $20.6B | $22.5B | -$687.6M | $11.9B | $12.1B | |
| Revenue Growth (YoY) | -8.56% | 9.38% | -- | -- | 1.57% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $261.5M | $327.7M | -- | -- | -- | |
| Other Inc / (Exp) | -$495.6M | $795.1M | $735.1M | -$54.1M | $728.4M | |
| Operating Expenses | $1.3B | $1.2B | $2.4B | $2.9B | $2.6B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $583.6M | $616.4M | $621.2M | $1.1B | $1.4B | |
| EBT. Incl. Unusual Items | $2.5B | $4.5B | $683.4M | $1.7B | $2.1B | |
| Earnings of Discontinued Ops. | $131.3M | $159.7M | $1.1B | -- | -- | |
| Income Tax Expense | $439.7M | $791.5M | $113.9M | $376.7M | $361.5M | |
| Net Income to Company | $2.7B | $4.7B | $1.8B | $1.7B | $2.1B | |
| Minority Interest in Earnings | -$25.1M | -$23.7M | $5.3M | -$13M | -$20.6M | |
| Net Income to Common Excl Extra Items | $2.2B | $3.9B | $1.7B | $1.3B | $1.7B | |
| Basic EPS (Cont. Ops) | $3.36 | $6.16 | $2.81 | $2.19 | $3.02 | |
| Diluted EPS (Cont. Ops) | $3.35 | $6.16 | $2.81 | $2.19 | $3.02 | |
| Weighted Average Basic Share | $628.2M | $617.8M | $591M | $554.6M | $543.4M | |
| Weighted Average Diluted Share | $629.2M | $618.6M | $591.4M | $555M | $543.8M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $3.1B | $5.2B | $683.4M | $1.7B | $2.1B | |
| Revenue (Reported) | $20.6B | $22.5B | -$687.6M | $11.9B | $12.1B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $3.1B | $5.2B | $683.4M | $1.7B | $2.1B | |
| Period Ending | 2015-12-31 | 2016-12-31 | 2017-12-31 | 2018-12-31 | 2019-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.9B | $2.5B | $5.4B | $5.3B | $4.5B | |
| Revenue Growth (YoY) | -54.81% | -10.67% | 110.23% | -1% | -14.33% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $32.8M | -$127.3M | -$43.6M | -$49.1M | -$35.4M | |
| Operating Expenses | $1.7B | $1.7B | $3.7B | $3B | $3.4B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $377.5M | $170.5M | $876.1M | -$438.1M | $374.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$18.6M | $10.8M | $37.7M | $162M | $5.5M | |
| Net Income to Company | -- | $162.7M | $765.8M | -$416.6M | $394.2M | |
| Minority Interest in Earnings | -$2.2M | -- | -$14.1M | -$8M | -$4.4M | |
| Net Income to Common Excl Extra Items | $393.9M | $159.7M | $824.3M | -$608.1M | $364.3M | |
| Basic EPS (Cont. Ops) | $0.58 | $0.23 | $1.21 | -$0.94 | $0.54 | |
| Diluted EPS (Cont. Ops) | $0.57 | $0.23 | $1.20 | -$0.94 | $0.54 | |
| Weighted Average Basic Share | $664.8M | $650.6M | $671.2M | $671.6M | $649M | |
| Weighted Average Diluted Share | $667.2M | $652.2M | $673.2M | $672.8M | $650M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $538.3M | $257.8M | $891.4M | -$304.6M | $523.8M | |
| Revenue (Reported) | $2.9B | $2.5B | $5.4B | $5.3B | $4.5B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $538.3M | $257.8M | $891.4M | -$304.6M | $523.8M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $20.6B | $22.3B | -$775.4M | $11.9B | $11.9B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -$513.3M | $789.2M | $752.7M | -$52.7M | $722.9M | |
| Operating Expenses | $931.2M | $847.3M | $2.4B | $2.9B | $2.6B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $584.7M | $611.6M | $614.2M | $1.1B | $1.4B | |
| EBT. Incl. Unusual Items | $2.5B | $4.5B | $695.2M | $1.7B | $2.1B | |
| Earnings of Discontinued Ops. | -- | $158.6M | $1.2B | -- | -- | |
| Income Tax Expense | $436.4M | $785.6M | $115.8M | $377M | $357.8M | |
| Net Income to Company | -- | $4.7B | $1.9B | $1.7B | -- | |
| Minority Interest in Earnings | -$25.3M | -$23.6M | $5.7M | -$13M | -$20.4M | |
| Net Income to Common Excl Extra Items | $2.2B | $3.8B | $1.7B | $1.3B | $1.7B | |
| Basic EPS (Cont. Ops) | $3.42 | $6.10 | $2.85 | $2.19 | $2.99 | |
| Diluted EPS (Cont. Ops) | $3.42 | $6.09 | $2.85 | $2.18 | $2.98 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $3.1B | $5.1B | -- | -- | -- | |
| Revenue (Reported) | $20.6B | $22.3B | -$775.4M | $11.9B | $11.9B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $3.1B | $5.1B | -- | -- | -- | |
| Period Ending | 2021-05-07 | 2022-05-07 | 2023-05-07 | 2024-05-07 | ||
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -- | -- | -- | -- | -- | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $15.2B | $7.8B | $7.2B | $9.1B | $7.2B | |
| Short Term Investments | $145.4B | $169.8B | $123.4B | $121.7B | $110.4B | |
| Accounts Receivable, Net | $890.5M | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $19.7M | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $163.7B | $177.6B | $132.5B | $132.9B | $119.8B | |
| Property Plant And Equipment | $551M | $468.7M | $427.9M | $384.7M | $314.3M | |
| Long-Term Investments | $172.2B | $263B | $177.9B | $182.3B | $174.5B | |
| Goodwill | $655.6M | -- | $934.1M | $986M | $904.3M | |
| Other Intangibles | $651.9M | $1.1B | $438.6M | $417.8M | $374.6M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $324.4B | $284.7B | $222B | $231B | $218.9B | |
| Accounts Payable | $1.2B | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $3.6B | -- | $1.3B | $1.1B | $963.6M | |
| Long-Term Debt | $14.3B | $13.5B | $16.2B | $15.3B | $12B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $276.7B | $257.9B | $199.4B | $207.6B | $196.4B | |
| Common Stock | $48M | $24.5B | $37.5M | $37.6M | $33.3M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $47.3B | $26.5B | $22.6B | $23.3B | $22.4B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $340.7M | $276.3M | $77.2M | $87.3M | $88.4M | |
| Total Equity | $47.7B | $26.8B | $22.6B | $23.3B | $22.5B | |
| Total Liabilities and Equity | $324.4B | $284.7B | $222B | $231B | $218.9B | |
| Cash and Short Terms | $160.6B | $177.6B | $130.5B | $130.8B | $117.6B | |
| Total Debt | $14.3B | $13.5B | $16.2B | $15.3B | $12B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $15.2B | $7.8B | $7.2B | $9.1B | $7.2B | |
| Short Term Investments | $145.4B | $169.8B | $123.4B | $121.7B | $110.4B | |
| Accounts Receivable, Net | $890.5M | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $19.7M | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $163.7B | $177.6B | $132.5B | $132.9B | $119.8B | |
| Property Plant And Equipment | $551M | $468.7M | $427.9M | $384.7M | $314.3M | |
| Long-Term Investments | $172.2B | $263B | $177.9B | $182.3B | $174.5B | |
| Goodwill | $655.6M | -- | $934.1M | $986M | $904.3M | |
| Other Intangibles | $651.9M | $1.1B | $438.6M | $417.8M | $374.6M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $324.4B | $284.7B | $222B | $231B | $218.9B | |
| Accounts Payable | $1.2B | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $3.6B | -- | $1.3B | $1.1B | $963.6M | |
| Long-Term Debt | $14.3B | $13.5B | $16.2B | $15.3B | $12B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $276.7B | $257.9B | $199.4B | $207.6B | $196.4B | |
| Common Stock | $48M | $24.5B | $37.5M | $37.6M | $33.3M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $340.7M | $276.3M | $77.2M | $87.3M | $88.4M | |
| Total Equity | $47.7B | $26.8B | $22.6B | $23.3B | $22.5B | |
| Total Liabilities and Equity | $324.4B | $284.7B | $222B | $231B | $218.9B | |
| Cash and Short Terms | $160.6B | $177.6B | $130.5B | $130.8B | $117.6B | |
| Total Debt | $14.3B | $13.5B | $16.2B | $15.3B | $12B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.7B | $4.7B | $1.8B | $1.7B | $2.1B | |
| Depreciation & Amoritzation | $179.3M | $177.5M | $154M | $164.6M | $169.9M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $8B | -$3.1B | -$8.6B | $67.1M | -$434M | |
| Capital Expenditures | $58.2M | $55.6M | -- | -- | -- | |
| Cash Acquisitions | -$875.9M | -$952.5M | $1.2B | -$267.4M | -$489.2M | |
| Cash From Investing | $628.1M | -$2.2B | $6.3B | $4.9B | $2.8B | |
| Dividends Paid (Ex Special Dividend) | -$456.8M | -$526.5M | -$564.2M | -$463.4M | -$750.1M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $5.9B | $2.8B | $11.2B | $11.5B | $8.7B | |
| Long-Term Debt Repaid | -$6.3B | -$2.4B | -$7.2B | -$13.5B | -$11B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$1.7B | -$876.7M | $1.9B | -$3.2B | -$3.7B | |
| Beginning Cash (CF) | $7.4B | $14.7B | $7.5B | $7.2B | $8.9B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $6.9B | -$6.1B | -$361.7M | $1.7B | -$1.3B | |
| Ending Cash (CF) | $14.1B | $8.5B | $7B | $8.9B | $7.5B | |
| Levered Free Cash Flow | $7.9B | -$3.1B | -$8.6B | $67.1M | -$434M | |
| Period Ending | 2015-12-31 | 2016-12-31 | 2017-12-31 | 2018-12-31 | 2019-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | $162.7M | $765.8M | -$416.6M | $394.2M | |
| Depreciation & Amoritzation | -- | $13M | $56.7M | $60.5M | $42.2M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -$1.8B | -$18.6M | -$1.3B | -$3.9B | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -$10.9B | -$303.3M | $106.9M | -$71.9M | |
| Cash From Investing | -- | $501.9M | $694.4M | $1.6B | -$986.8M | |
| Dividends Paid (Ex Special Dividend) | -- | $2.8M | -$6.4M | -$50.6M | -$18.7M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $4B | $5.8B | $493.4M | $234.7M | |
| Long-Term Debt Repaid | -- | -$3.5B | -$6.7B | -$226M | $412.1M | |
| Repurchase of Common Stock | -- | -$556.7M | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | $487.2M | -$1B | -$49.5M | $411M | |
| Beginning Cash (CF) | -- | $10.2B | $11.4B | $9.9B | $11.7B | |
| Foreign Exchange Rate Adjustment | -- | $199.7M | -$14.2M | $107.9M | -$78.7M | |
| Additions / Reductions | -- | -$782.4M | -$354.3M | $285.5M | -$4.5B | |
| Ending Cash (CF) | -- | $9.6B | $10.6B | $10.5B | $7.2B | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | $4.5B | $707.9M | -- | |
| Depreciation & Amoritzation | -- | -- | $168.1M | $156.4M | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -$8.7B | -$1.4B | -- | |
| Capital Expenditures | -- | $24.1M | $30.9M | -- | -- | |
| Cash Acquisitions | -- | -$329M | $178.7M | $409.4M | -$239.1M | |
| Cash From Investing | -- | -- | $6.4B | $4.2B | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -$308.5M | -$485.6M | -$573M | -$179.8M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $7.1B | $12.2B | -- | |
| Long-Term Debt Repaid | -- | -- | -$4.1B | -$12.1B | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | $1.5B | -$1.7B | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -$831.4M | $1.1B | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -$8.7B | -$1.4B | -- | |
| Period Ending | 2021-05-07 | 2022-05-07 | 2023-05-07 | 2024-05-07 | ||
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Get NNGRY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
NNGRY
Sector
P/E ratio
10.38x
11.37x
PEG ratio
2.18x
0.38x
P/B ratio
0.74x
1.04x
Price / LTM sales
1.41x
2.45x
Growth Metrics
NNGRY
Sector
Revenue growth
--
5.74%
Earnings growth
--
6.25%
Revenue (5-year growth)
-11.71%
5.15%
Earnings forecast
--
$0.57
Profitability
NNGRY
Sector
Profitability FY 2025
--
$150.9M
Return on invested capital
4.67%
5.47%
Return on assets
0.76%
0.98%
Return on equity
7.41%
9.38%
Earnings Date
Last Earnings Date
Feb
20
Next Earnings Date
Aug
8
Estimated Next Earnings Date
May
22
Balance Sheet
NNGRY
Sector
Total cash
$117.6B
$523.5M
Short term investments
$110.4B
$237.7M
Total assets
$218.9B
$4.1B
Long term debt
$12B
$299.6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire The Best Stock to Buy in a Bad Market?
Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…
Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?
The big picture trends in e‑commerce sales are clearly in…
Stock Ideas
Buy
71
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
63
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
60
RGC alert for May 6
Regencell Bioscience Holdings [RGC] is up 73.72% over the past day.
Buy
63
SKX alert for May 6
Skechers USA [SKX] is down 0.07% over the past day.
Sell
20
PTCT alert for May 6
PTC Therapeutics [PTCT] is down 11% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
